Anthracyclines - Global and China Top Players Market Share and Ranking 2023
According to Latest Research, the global market for Anthracyclines should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Anthracyclines market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Anthracyclines market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Leukemia grew percent to account for percent of the total market sales, and Hodgkin Lymphoma grew percent.
Anthracycline is a type of antibiotic that is extracted from numerous types of Streptomyces bacteria. They are used for the treatment of various types of cancer. It damages the DNA of cancer cells and stop its function. This can be done either by intercalating into the base pairs in the DNA minor grooves or by causing free radical damage of the ribose in the DNA. Daunorubicin, doxorubicin, and epirubicin are some of the top examples of anthracyclines.
This report studies and analyses global Anthracyclines status and future trends, helps the client to determine the Anthracyclines market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Anthracyclines, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Anthracyclines market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Anthracyclines sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Anthracyclines sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Anthracyclines key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Anthracyclines key producing regions, capacity, production, and year over year growth
(6) Anthracyclines industry chains, upstream, midstream and downstream
Market segment by players, this report covers
AstraZeneca
Sun Pharmaceutical Industries Ltd
Merck & Co., Inc
Lilly
Amgen Inc
GSK plc
Johnson & Johnson Services, Inc
Pfizer Inc
Meiji Holdings Co., Ltd
MicroBiopharm Japan Co., Ltd
Synbias Pharma
Hikma Pharmaceuticals PLC
Cumberland Pharmaceuticals Inc
Cadila Pharmaceuticals
Cipla Inc
Market segment by Type, covers
Oral
Parenteral
Market segment by Application, can be divided into
Leukemia
Hodgkin Lymphoma
Bladder Cancer
Breast Cancer
Other
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Anthracyclines product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Anthracyclines market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Anthracyclines market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Anthracyclines, percent & CAGR, 2018-2029
Chapter 5: Anthracyclines industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Anthracyclines Definition
1.2 Global Anthracyclines Market Size and Forecast
1.2.1 By Consumption Value, Global Anthracyclines Market Size，2018-2029
1.2.2 By Sales Quantity, Global Anthracyclines Market Size，2018-2029
1.2.3 Global Anthracyclines Average Selling Price (ASP)，2018-2029
1.3 China Anthracyclines Market Size and Forecast
1.3.1 By Consumption Value, China Anthracyclines Market Size，2018-2029
1.3.2 By Sales Quantity, China Anthracyclines Market Size，2018-2029
1.3.3 China Anthracyclines Average Selling Price (ASP)， 2018-2029
1.4 Share of China Anthracyclines Market with Respect to the Global Market
1.4.1 By Consumption Value, China Anthracyclines Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Anthracyclines Market Share in Global, 2018-2029
1.4.3 Anthracyclines Market Size: China VS Global, 2018-2029
1.5 Anthracyclines Market Dynamics
1.5.1 Anthracyclines Market Drivers
1.5.2 Anthracyclines Market Restraints
1.5.3 Anthracyclines Industry Trends
1.5.4 Anthracyclines Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Anthracyclines, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Anthracyclines, Global Market Share by Company, 2018-2023
2.3 Anthracyclines Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Anthracyclines Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Anthracyclines Concentration Ratio
2.6 Global Anthracyclines Mergers & Acquisitions, Expansion Plans
2.7 Global Anthracyclines Manufacturers Product Type
2.8 Head Office and Anthracyclines Production Site of Key Manufacturer
2.9 Anthracyclines Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Anthracyclines, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Anthracyclines, China Market Share by Company, 2018-2023
3.3 China Anthracyclines Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Anthracyclines Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Anthracyclines Capacity by Region
4.3 Global Anthracyclines Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Anthracyclines Production by Region, 2018-2029
4.5 Global Anthracyclines Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Anthracyclines Industry Chain
5.2 Anthracyclines Upstream Analysis
5.2.1 Anthracyclines Core Raw Materials
5.2.2 Main Manufacturers of Anthracyclines Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Anthracyclines Production Mode
5.6 Anthracyclines Procurement Model
5.7 Anthracyclines Industry Sales Model and Sales Channels
5.7.1 Anthracyclines Sales Model
5.7.2 Anthracyclines Typical Distributors
6 Sights by Type
6.1 Anthracyclines Classification
6.1.1 Oral
6.1.2 Parenteral
6.2 By Type, Global Anthracyclines Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Anthracyclines Consumption Value, 2018-2029
6.4 By Type, Global Anthracyclines Sales Quantity, 2018-2029
6.5 By Type, Global Anthracyclines Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Anthracyclines Segment by Application
7.1.1 Leukemia
7.1.2 Hodgkin Lymphoma
7.1.3 Bladder Cancer
7.1.4 Breast Cancer
7.1.5 Other
7.2 By Application, Global Anthracyclines Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Anthracyclines Consumption Value, 2018-2029
7.4 By Application, Global Anthracyclines Sales Quantity, 2018-2029
7.5 By Application, Global Anthracyclines Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Anthracyclines Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Anthracyclines Consumption Value, 2018-2029
8.3 By Region, Global Anthracyclines Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Anthracyclines & Forecasts, 2018-2029
8.4.2 By Country, North America Anthracyclines Market Size Market Share
8.5 Europe
8.5.1 Europe Anthracyclines Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Anthracyclines Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Anthracyclines Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Anthracyclines Market Size Market Share
8.7 South America
8.7.1 South America Anthracyclines Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Anthracyclines Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Anthracyclines Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Anthracyclines Consumption Value, 2018-2029
9.3 By Country, Global Anthracyclines Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Anthracyclines Market Size, 2018-2029
9.4.2 By Type, U.S. Anthracyclines Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Anthracyclines Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Anthracyclines Market Size, 2018-2029
9.5.2 By Type, Europe Anthracyclines Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Anthracyclines Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Anthracyclines Market Size, 2018-2029
9.6.2 By Type, China Anthracyclines Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Anthracyclines Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Anthracyclines Market Size, 2018-2029
9.7.2 By Type, Japan Anthracyclines Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Anthracyclines Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Anthracyclines Market Size, 2018-2029
9.8.2 By Type, South Korea Anthracyclines Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Anthracyclines Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Anthracyclines Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Anthracyclines Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Anthracyclines Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Anthracyclines Market Size, 2018-2029
9.10.2 By Type, India Anthracyclines Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Anthracyclines Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Anthracyclines Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Anthracyclines Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Anthracyclines Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 AstraZeneca
10.1.1 AstraZeneca Company Information, Head Office, Market Area, and Industry Position
10.1.2 AstraZeneca Anthracyclines Models, Specifications, and Application
10.1.3 AstraZeneca Anthracyclines Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 AstraZeneca Company Profile and Main Business
10.1.5 AstraZeneca Recent Developments
10.2 Sun Pharmaceutical Industries Ltd
10.2.1 Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area, and Industry Position
10.2.2 Sun Pharmaceutical Industries Ltd Anthracyclines Models, Specifications, and Application
10.2.3 Sun Pharmaceutical Industries Ltd Anthracyclines Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Sun Pharmaceutical Industries Ltd Company Profile and Main Business
10.2.5 Sun Pharmaceutical Industries Ltd Recent Developments
10.3 Merck & Co., Inc
10.3.1 Merck & Co., Inc Company Information, Head Office, Market Area, and Industry Position
10.3.2 Merck & Co., Inc Anthracyclines Models, Specifications, and Application
10.3.3 Merck & Co., Inc Anthracyclines Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Merck & Co., Inc Company Profile and Main Business
10.3.5 Merck & Co., Inc Recent Developments
10.4 Lilly
10.4.1 Lilly Company Information, Head Office, Market Area, and Industry Position
10.4.2 Lilly Anthracyclines Models, Specifications, and Application
10.4.3 Lilly Anthracyclines Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Lilly Company Profile and Main Business
10.4.5 Lilly Recent Developments
10.5 Amgen Inc
10.5.1 Amgen Inc Company Information, Head Office, Market Area, and Industry Position
10.5.2 Amgen Inc Anthracyclines Models, Specifications, and Application
10.5.3 Amgen Inc Anthracyclines Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Amgen Inc Company Profile and Main Business
10.5.5 Amgen Inc Recent Developments
10.6 GSK plc
10.6.1 GSK plc Company Information, Head Office, Market Area, and Industry Position
10.6.2 GSK plc Anthracyclines Models, Specifications, and Application
10.6.3 GSK plc Anthracyclines Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 GSK plc Company Profile and Main Business
10.6.5 GSK plc Recent Developments
10.7 Johnson & Johnson Services, Inc
10.7.1 Johnson & Johnson Services, Inc Company Information, Head Office, Market Area, and Industry Position
10.7.2 Johnson & Johnson Services, Inc Anthracyclines Models, Specifications, and Application
10.7.3 Johnson & Johnson Services, Inc Anthracyclines Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Johnson & Johnson Services, Inc Company Profile and Main Business
10.7.5 Johnson & Johnson Services, Inc Recent Developments
10.8 Pfizer Inc
10.8.1 Pfizer Inc Company Information, Head Office, Market Area, and Industry Position
10.8.2 Pfizer Inc Anthracyclines Models, Specifications, and Application
10.8.3 Pfizer Inc Anthracyclines Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Pfizer Inc Company Profile and Main Business
10.8.5 Pfizer Inc Recent Developments
10.9 Meiji Holdings Co., Ltd
10.9.1 Meiji Holdings Co., Ltd Company Information, Head Office, Market Area, and Industry Position
10.9.2 Meiji Holdings Co., Ltd Anthracyclines Models, Specifications, and Application
10.9.3 Meiji Holdings Co., Ltd Anthracyclines Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Meiji Holdings Co., Ltd Company Profile and Main Business
10.9.5 Meiji Holdings Co., Ltd Recent Developments
10.10 MicroBiopharm Japan Co., Ltd
10.10.1 MicroBiopharm Japan Co., Ltd Company Information, Head Office, Market Area, and Industry Position
10.10.2 MicroBiopharm Japan Co., Ltd Anthracyclines Models, Specifications, and Application
10.10.3 MicroBiopharm Japan Co., Ltd Anthracyclines Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 MicroBiopharm Japan Co., Ltd Company Profile and Main Business
10.10.5 MicroBiopharm Japan Co., Ltd Recent Developments
10.11 Synbias Pharma
10.11.1 Synbias Pharma Company Information, Head Office, Market Area, and Industry Position
10.11.2 Synbias Pharma Anthracyclines Models, Specifications, and Application
10.11.3 Synbias Pharma Anthracyclines Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Synbias Pharma Company Profile and Main Business
10.11.5 Synbias Pharma Recent Developments
10.12 Hikma Pharmaceuticals PLC
10.12.1 Hikma Pharmaceuticals PLC Company Information, Head Office, Market Area, and Industry Position
10.12.2 Hikma Pharmaceuticals PLC Anthracyclines Models, Specifications, and Application
10.12.3 Hikma Pharmaceuticals PLC Anthracyclines Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Hikma Pharmaceuticals PLC Company Profile and Main Business
10.12.5 Hikma Pharmaceuticals PLC Recent Developments
10.13 Cumberland Pharmaceuticals Inc
10.13.1 Cumberland Pharmaceuticals Inc Company Information, Head Office, Market Area, and Industry Position
10.13.2 Cumberland Pharmaceuticals Inc Anthracyclines Models, Specifications, and Application
10.13.3 Cumberland Pharmaceuticals Inc Anthracyclines Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Cumberland Pharmaceuticals Inc Company Profile and Main Business
10.13.5 Cumberland Pharmaceuticals Inc Recent Developments
10.14 Cadila Pharmaceuticals
10.14.1 Cadila Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.14.2 Cadila Pharmaceuticals Anthracyclines Models, Specifications, and Application
10.14.3 Cadila Pharmaceuticals Anthracyclines Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Cadila Pharmaceuticals Company Profile and Main Business
10.14.5 Cadila Pharmaceuticals Recent Developments
10.15 Cipla Inc
10.15.1 Cipla Inc Company Information, Head Office, Market Area, and Industry Position
10.15.2 Cipla Inc Anthracyclines Models, Specifications, and Application
10.15.3 Cipla Inc Anthracyclines Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Cipla Inc Company Profile and Main Business
10.15.5 Cipla Inc Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Anthracyclines Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Anthracyclines Market Restraints
Table 3. Anthracyclines Market Trends
Table 4. Anthracyclines Industry Policy
Table 5. Global Anthracyclines Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Anthracyclines Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Anthracyclines Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Anthracyclines Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Anthracyclines Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Anthracyclines Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Anthracyclines Mergers & Acquisitions, Expansion Plans
Table 12. Global Anthracyclines Manufacturers Product Type
Table 13. Head Office and Anthracyclines Production Site of Key Manufacturer
Table 14. Anthracyclines Capacity of Major Manufacturers and Future Plan
Table 15. China Anthracyclines Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Anthracyclines Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Anthracyclines Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Anthracyclines Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Anthracyclines Production by Region, 2018-2023, (K Units)
Table 20. Global Anthracyclines Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Anthracyclines Upstream (Raw Materials)
Table 22. Global Anthracyclines Typical Customers
Table 23. Anthracyclines Typical Distributors
Table 24. By Type, Global Anthracyclines Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Anthracyclines Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Anthracyclines Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Anthracyclines Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Anthracyclines Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Anthracyclines Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Anthracyclines Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Anthracyclines Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Anthracyclines Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Anthracyclines Sales Quantity Market Share, 2018-2029
Table 34. AstraZeneca Company Information, Head Office, Market Area, and Industry Position
Table 35. AstraZeneca Anthracyclines Models, Specifications, and Application
Table 36. AstraZeneca Anthracyclines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. AstraZeneca Company Profile and Main Business
Table 38. AstraZeneca Recent Developments
Table 39. Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area, and Industry Position
Table 40. Sun Pharmaceutical Industries Ltd Anthracyclines Models, Specifications, and Application
Table 41. Sun Pharmaceutical Industries Ltd Anthracyclines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Sun Pharmaceutical Industries Ltd Company Profile and Main Business
Table 43. Sun Pharmaceutical Industries Ltd Recent Developments
Table 44. Merck & Co., Inc Company Information, Head Office, Market Area, and Industry Position
Table 45. Merck & Co., Inc Anthracyclines Models, Specifications, and Application
Table 46. Merck & Co., Inc Anthracyclines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Merck & Co., Inc Company Profile and Main Business
Table 48. Merck & Co., Inc Recent Developments
Table 49. Lilly Company Information, Head Office, Market Area, and Industry Position
Table 50. Lilly Anthracyclines Models, Specifications, and Application
Table 51. Lilly Anthracyclines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Lilly Company Profile and Main Business
Table 53. Lilly Recent Developments
Table 54. Amgen Inc Company Information, Head Office, Market Area, and Industry Position
Table 55. Amgen Inc Anthracyclines Models, Specifications, and Application
Table 56. Amgen Inc Anthracyclines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Amgen Inc Company Profile and Main Business
Table 58. Amgen Inc Recent Developments
Table 59. GSK plc Company Information, Head Office, Market Area, and Industry Position
Table 60. GSK plc Anthracyclines Models, Specifications, and Application
Table 61. GSK plc Anthracyclines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. GSK plc Company Profile and Main Business
Table 63. GSK plc Recent Developments
Table 64. Johnson & Johnson Services, Inc Company Information, Head Office, Market Area, and Industry Position
Table 65. Johnson & Johnson Services, Inc Anthracyclines Models, Specifications, and Application
Table 66. Johnson & Johnson Services, Inc Anthracyclines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Johnson & Johnson Services, Inc Company Profile and Main Business
Table 68. Johnson & Johnson Services, Inc Recent Developments
Table 69. Pfizer Inc Company Information, Head Office, Market Area, and Industry Position
Table 70. Pfizer Inc Anthracyclines Models, Specifications, and Application
Table 71. Pfizer Inc Anthracyclines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Pfizer Inc Company Profile and Main Business
Table 73. Pfizer Inc Recent Developments
Table 74. Meiji Holdings Co., Ltd Company Information, Head Office, Market Area, and Industry Position
Table 75. Meiji Holdings Co., Ltd Anthracyclines Models, Specifications, and Application
Table 76. Meiji Holdings Co., Ltd Anthracyclines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Meiji Holdings Co., Ltd Company Profile and Main Business
Table 78. Meiji Holdings Co., Ltd Recent Developments
Table 79. MicroBiopharm Japan Co., Ltd Company Information, Head Office, Market Area, and Industry Position
Table 80. MicroBiopharm Japan Co., Ltd Anthracyclines Models, Specifications, and Application
Table 81. MicroBiopharm Japan Co., Ltd Anthracyclines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. MicroBiopharm Japan Co., Ltd Company Profile and Main Business
Table 83. MicroBiopharm Japan Co., Ltd Recent Developments
Table 84. Synbias Pharma Company Information, Head Office, Market Area, and Industry Position
Table 85. Synbias Pharma Anthracyclines Models, Specifications, and Application
Table 86. Synbias Pharma Anthracyclines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Synbias Pharma Company Profile and Main Business
Table 88. Synbias Pharma Recent Developments
Table 89. Hikma Pharmaceuticals PLC Company Information, Head Office, Market Area, and Industry Position
Table 90. Hikma Pharmaceuticals PLC Anthracyclines Models, Specifications, and Application
Table 91. Hikma Pharmaceuticals PLC Anthracyclines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Hikma Pharmaceuticals PLC Company Profile and Main Business
Table 93. Hikma Pharmaceuticals PLC Recent Developments
Table 94. Cumberland Pharmaceuticals Inc Company Information, Head Office, Market Area, and Industry Position
Table 95. Cumberland Pharmaceuticals Inc Anthracyclines Models, Specifications, and Application
Table 96. Cumberland Pharmaceuticals Inc Anthracyclines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Cumberland Pharmaceuticals Inc Company Profile and Main Business
Table 98. Cumberland Pharmaceuticals Inc Recent Developments
Table 99. Cadila Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 100. Cadila Pharmaceuticals Anthracyclines Models, Specifications, and Application
Table 101. Cadila Pharmaceuticals Anthracyclines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Cadila Pharmaceuticals Company Profile and Main Business
Table 103. Cadila Pharmaceuticals Recent Developments
Table 104. Cipla Inc Company Information, Head Office, Market Area, and Industry Position
Table 105. Cipla Inc Anthracyclines Models, Specifications, and Application
Table 106. Cipla Inc Anthracyclines Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Cipla Inc Company Profile and Main Business
Table 108. Cipla Inc Recent Developments
List of Figures
Figure 1. Anthracyclines Picture
Figure 2. Global Anthracyclines Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Anthracyclines Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Anthracyclines Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Anthracyclines Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Anthracyclines Sales Quantity (K Units) & (2018-2029)
Figure 7. China Anthracyclines Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Anthracyclines Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Anthracyclines Market Share of Global, 2018-2029
Figure 10. Global Anthracyclines Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Anthracyclines Key Participants, Market Share, 2022
Figure 12. Global Anthracyclines Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Anthracyclines Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Anthracyclines Production Market Share & Forecast by Region, 2018-2029
Figure 15. Anthracyclines Industry Chain
Figure 16. Anthracyclines Procurement Model
Figure 17. Anthracyclines Sales Model
Figure 18. Anthracyclines Sales Channels, Direct Sales, and Distribution
Figure 19. Oral
Figure 20. Parenteral
Figure 21. By Type, Global Anthracyclines Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global Anthracyclines Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global Anthracyclines Sales Quantity, 2018-2029, (K Units)
Figure 24. By Type, Global Anthracyclines Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global Anthracyclines Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 26. Leukemia
Figure 27. Hodgkin Lymphoma
Figure 28. Bladder Cancer
Figure 29. Breast Cancer
Figure 30. Other
Figure 31. By Application, Global Anthracyclines Consumption Value, 2018-2029, US$ Million
Figure 32. By Application, Global Anthracyclines Consumption Value Market Share, 2018-2029
Figure 33. By Application, Global Anthracyclines Sales Quantity, 2018-2029, (K Units)
Figure 34. By Application, Global Anthracyclines Sales Quantity Market Share, 2018-2029
Figure 35. By Application, Global Anthracyclines Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 36. By Region, Global Anthracyclines Consumption Value Market Share, 2018-2029
Figure 37. By Region, Global Anthracyclines Sales Quantity Market Share, 2018-2029
Figure 38. North America Anthracyclines Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, North America Anthracyclines Consumption Value Market Share, 2022
Figure 40. Europe Anthracyclines Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country, Europe Anthracyclines Consumption Value Market Share, 2022
Figure 42. Asia Pacific Anthracyclines Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country/Region, Asia Pacific Anthracyclines Consumption Value Market Share, 2022
Figure 44. South America Anthracyclines Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, South America Anthracyclines Consumption Value Market Share, 2022
Figure 46. Middle East & Africa Anthracyclines Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 47. U.S. Anthracyclines Sales Quantity, 2018-2029, (K Units)
Figure 48. By Type, U.S. Anthracyclines Sales Quantity Market Share, 2022 VS 2029
Figure 49. By Application, U.S. Anthracyclines Sales Quantity Market Share, 2022 VS 2029
Figure 50. Europe Anthracyclines Sales Quantity, 2018-2029, (K Units)
Figure 51. By Type, Europe Anthracyclines Sales Quantity Market Share, 2022 VS 2029
Figure 52. By Application, Europe Anthracyclines Sales Quantity Market Share, 2022 VS 2029
Figure 53. China Anthracyclines Sales Quantity, 2018-2029, (K Units)
Figure 54. By Type, China Anthracyclines Sales Quantity Market Share, 2022 VS 2029
Figure 55. By Application, China Anthracyclines Sales Quantity Market Share, 2022 VS 2029
Figure 56. Japan Anthracyclines Sales Quantity, 2018-2029, (K Units)
Figure 57. By Type, Japan Anthracyclines Sales Quantity Market Share, 2022 VS 2029
Figure 58. By Application, Japan Anthracyclines Sales Quantity Market Share, 2022 VS 2029
Figure 59. South Korea Anthracyclines Sales Quantity, 2018-2029, (K Units)
Figure 60. By Type, South Korea Anthracyclines Sales Quantity Market Share, 2022 VS 2029
Figure 61. By Application, South Korea Anthracyclines Sales Quantity Market Share, 2022 VS 2029
Figure 62. Southeast Asia Anthracyclines Sales Quantity, 2018-2029, (K Units)
Figure 63. By Type, Southeast Asia Anthracyclines Sales Quantity Market Share, 2022 VS 2029
Figure 64. By Application, Southeast Asia Anthracyclines Sales Quantity Market Share, 2022 VS 2029
Figure 65. India Anthracyclines Sales Quantity, 2018-2029, (K Units)
Figure 66. By Type, India Anthracyclines Sales Quantity Market Share, 2022 VS 2029
Figure 67. By Application, India Anthracyclines Sales Quantity Market Share, 2022 VS 2029
Figure 68. Middle East & Africa Anthracyclines Sales Quantity, 2018-2029, (K Units)
Figure 69. By Type, Middle East & Africa Anthracyclines Sales Quantity Market Share, 2022 VS 2029
Figure 70. By Application, Middle East & Africa Anthracyclines Sales Quantity Market Share, 2022 VS 2029
Figure 71. Research Methodology
Figure 72. Breakdown of Primary Interviews
Figure 73. Bottom-up and Top-down Approaches
Figure 74. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|